Metastatic colorectal carcinoma patients: The Glasgow prognostic score (GPS) at the era of anti-VEGF therapies

被引：0
|
作者：
Maillet, M. [1 ]
Dreanic, J. [1 ]
Dhooge, M. [1 ]
Cessot, A. [1 ]
Mir, O. [1 ]
Brezault, C. [1 ]
Goldwasser, F. [1 ]
Chaussade, S. [1 ]
Coriat, R. [1 ]
机构：
[1] Hop Cochin, F-75674 Paris, France
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2291
引用
收藏
页码：S526 / S526
页数：1
相关论文
共 50 条
  • [21] PROGNOSTIC VALUE OF THE GLASGOW PROGNOSTIC SCORE FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH CYTOREDUCTIVE NEPHRECTOMY
    Fukuda, Hironori
    Takagi, Toshio
    Kondo, Tsunenori
    Yoshida, Kazuhiko
    Shimizu, Satoru
    Nagashima, Yoji
    Tanabe, Kazunari
    JOURNAL OF UROLOGY, 2018, 199 (04): : E490 - E490
  • [22] Role of the Modified Glasgow Prognostic Score (mGPS) as a Prognostic Factor in Metastatic Colorectal Cancer
    Cotan, Horia
    Iaciu, Cristian
    Nitipir, Cornelia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [23] The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer
    Lieu, Christopher H.
    Hai Tran
    Jiang, Zhi-Qin
    Mao, Muling
    Overman, Michael J.
    Lin, E.
    Eng, Cathy
    Morris, Jeffrey
    Ellis, Lee
    Heymach, John V.
    Kopetz, Scott
    PLOS ONE, 2013, 8 (10):
  • [24] Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
    Lu, Lingling
    Lin, Kunzhe
    Zheng, Jiaolong
    Wu, Haicong
    Li, Dongliang
    BMJ OPEN, 2021, 11 (12):
  • [25] The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)
    He, Kuifeng
    Cui, Binbin
    Li, Guangliang
    Wang, Haohao
    Jin, Ketao
    Teng, Lisong
    ONCOTARGETS AND THERAPY, 2012, 5 : 59 - 65
  • [26] Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis
    Okimoto, Sho
    Kobayashi, Tsuyoshi
    Tashiro, Hirotaka
    Kuroda, Shintaro
    Ishiyama, Kohei
    Ide, Kentaro
    Abe, Tomoyuki
    Hashimoto, Masakazu
    Iwako, Hiroshi
    Hamaoka, Michinori
    Honmyo, Naruhiko
    Yamaguchi, Megumi
    Ohdan, Hideki
    INTERNATIONAL JOURNAL OF SURGERY, 2017, 42 : 209 - 214
  • [27] Toxicities of anti-VEGF therapies used in metastatic renal cell carcinoma: A real-world experience.
    Master, Samip R.
    Findakly, Dawood
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16533 - E16533
  • [28] An Inflammation-Based Prognostic Score, The Glasgow Prognostic Score (gps), Has Prognostic Significance In Patients With Pneumonia
    Ikeo, S.
    Kumagai, S.
    Ito, Y.
    Ito, A.
    Tachibana, H.
    Hashimoto, T.
    Ishida, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [29] The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer.
    Lieu, C. H.
    Tran, H. T.
    Jiang, Z.
    Mao, M.
    Overman, M. J.
    Eng, C.
    Morris, J.
    Ellis, L. M.
    Heymach, J.
    Kopetz, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer
    Lin, Mao-Song
    Huang, Jun-Xing
    Yu, Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 19138 - 19143
12345